We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

42 hedge funds and large institutions have $79.2M invested in Jasper Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 5

27% more funds holding

Funds holding: 33 → 42 (+9)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

11% more capital invested

Capital invested by funds: $71.2M → $79.2M (+$7.99M)

Holders
42
Holders Change
+9
Holders Change %
+27.27%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
7
Closed
5
Calls
$194K
Puts
–
Net Calls
+$194K
Net Calls Change
+$24K

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$5.62M
2
Goldman Sachs
Goldman Sachs
New York
+$5.19M
3
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$4.75M
4
RCM
Rivernorth Capital Management
Florida
+$1.93M
5
BCM
Beryl Capital Management
California
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
OCAM
Owl Creek Asset Management
New York
-$8.82M
2
AA
AQR Arbitrage
Connecticut
-$2.31M
3
LIM
Longfellow Investment Management
Massachusetts
-$1.93M
4
MIM
Monashee Investment Management
Massachusetts
-$1.79M
5
UOC
UBS O'Connor
Illinois
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Shaolin Capital Management
Florida
$769K +$500K +5,000 +182%
Walleye Trading
27
Walleye Trading
New York
$610K +$615K +6,150 New
DIG
28
DeepCurrents Investment Group
New York
$509K +$514K +5,138 New
AA
29
AQR Arbitrage
Connecticut
$496K -$2.31M -23,125 -82%
CCM
30
Context Capital Management
California
$496K +$500K +5,000 New
CPF
31
Context Partners Fund
California
$496K +$500K +5,000 New
CAC
32
Cowen and Company
New York
$347K +$350K +3,500 New
HF
33
HRT Financial
New York
$342K +$345K +3,449 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$331K – – –
SCM
35
Saba Capital Management
New York
$298K +$300K +3,000 New
CS
36
Credit Suisse
Switzerland
$273K – – –
CAPTRUST Financial Advisors
37
CAPTRUST Financial Advisors
North Carolina
$215K -$1.5K -15 -0.7%
EIP
38
Easterly Investment Partners
Massachusetts
$198K – – –
Citigroup
39
Citigroup
New York
$198K +$200K +2,000 New
MAM
40
Marquette Asset Management
Minnesota
$134K – – –
PAM
41
Panagora Asset Management
Massachusetts
$77K +$77.5K +775 New
UBS Group
42
UBS Group
Switzerland
$7K -$11.4K -114 -63%
OCAM
43
Owl Creek Asset Management
New York
– -$8.82M -86,100 Closed
LIM
44
Longfellow Investment Management
Massachusetts
– -$1.93M -18,777 Closed
MIM
45
Monashee Investment Management
Massachusetts
– -$1.79M -17,500 Closed
BFM
46
Boothbay Fund Management
New York
– -$614K -6,060 Closed
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– -$2K -22 Closed
1
2

JSPR Hedge Fund Activity: Q3 2020 in Review

42 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q3 2020, worth a combined $79.2M — up 11% from $71.2M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new JSPR positions and 5 closed out — a net gain of 9 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Glazer Capital LLC, adding an estimated $5.62M. The largest seller was Owl Creek Asset Management, exiting entirely with an estimated $8.82M sold.

  • 42 institutional investors held Jasper Therapeutics (JSPR) as of Q3 2020, up from 33 in Q2 2020.
  • Funds reported $79.2M of Jasper Therapeutics stock for Q3 2020, up 11% quarter-over-quarter.
  • 14 funds opened new Jasper Therapeutics positions in Q3 2020 and 5 closed out, a net change of +9 holders.
  • The largest Jasper Therapeutics buyer in Q3 2020 was Glazer Capital LLC, an estimated $5.62M added.
  • The largest Jasper Therapeutics seller in Q3 2020 was Owl Creek Asset Management, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2020.